M
Michael J. Fine
Researcher at University of Pittsburgh
Publications - 294
Citations - 35302
Michael J. Fine is an academic researcher from University of Pittsburgh. The author has contributed to research in topics: Community-acquired pneumonia & Pneumonia. The author has an hindex of 84, co-authored 285 publications receiving 32890 citations. Previous affiliations of Michael J. Fine include Veterans Health Administration & University of Lausanne.
Papers
More filters
Journal ArticleDOI
Acceptance of Antidepressant Treatment by Patients on Hemodialysis and Their Renal Providers
Julio E. Pena-Polanco,Maria K. Mor,Fadi A. Tohme,Michael J. Fine,Paul M. Palevsky,Steven D. Weisbord +5 more
TL;DR: Patients on chronic hemodialysis with depression are frequently not interested in modifying or initiating antidepressant treatment, commonly attributing their depression to a recent acute event, chronic illness, or dialysis, and renal providers are often unwilling to modify or initiate antidepressant therapy.
Journal ArticleDOI
Clinical features and predictors of mortality in admitted patients with community- and hospital-acquired legionellosis: a Danish historical cohort study.
TL;DR: Signs and symptoms were less pronounced in HAL compared to CAL and 30-day case fatality was almost 3 times higher than in CAL, suggesting clinical awareness is important for the timely diagnosis and treatment of legionellosis.
Journal ArticleDOI
Investigation of the ability of the Pneumonia Severity Index to accurately predict clinically relevant outcomes: a European study
B. Renaud,E. Coma,J. Hayon,Mercè Gurguí,C. Longo,M. Blancher,I. Jouannic,S. Betoulle,E. Roupie,Michael J. Fine +9 more
TL;DR: In two independent European cohorts, the PSI predicted patient outcomes accurately and reliably, particularly for low-risk patients, and the sensitivity and negative predictive value of low- risk classification for mortality exceeded 93% and 98%, respectively.
Journal ArticleDOI
Dual use of Department of Veterans Affairs and medicare benefits and use of test strips in veterans with type 2 diabetes mellitus.
Walid F. Gellad,Walid F. Gellad,Xinhua Zhao,Carolyn T. Thorpe,Carolyn T. Thorpe,Maria K. Mor,Maria K. Mor,Chester B. Good,Michael J. Fine,Michael J. Fine +9 more
TL;DR: Veterans who receive glucose test strips through both theVA and Medicare use more strips and are more likely to potentially overuse strips, illustrating the profound importance of understanding dual VA and Medicare coverage.
Journal ArticleDOI
Brand-Name Prescription Drug Use Among Veterans Affairs and Medicare Part D Patients With Diabetes: A National Cohort Comparison
Walid F. Gellad,Julie M. Donohue,Xinhua Zhao,Maria K. Mor,Carolyn T. Thorpe,Jeremy M. Smith,Chester B. Good,Michael J. Fine,Nancy E. Morden +8 more
TL;DR: Medicare beneficiaries with diabetes use 2 to 3 times more brand-name drugs than a comparable group within the VA, at substantial excess cost, which would have been $1.4 billion less if brand- name drug use matched that of the VA.